These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Optimising low-dose methotrexate for rheumatoid arthritis-A review.
    Author: Lucas CJ, Dimmitt SB, Martin JH.
    Journal: Br J Clin Pharmacol; 2019 Oct; 85(10):2228-2234. PubMed ID: 31276602.
    Abstract:
    Methotrexate at low doses (5-25 mg/week) is first-line therapy for rheumatoid arthritis. However, there is inter- and intrapatient variability in response, with contribution of variability in concentrations of active polyglutamate metabolites, associated with clinical efficacy and toxicity. Prescribing remains heterogeneous across population groups, disease states and regimens. This review examines current knowledge of dose-response of oral methotrexate in the setting of rheumatoid arthritis, and how this could help inform dosage regimens.
    [Abstract] [Full Text] [Related] [New Search]